Alterity Therapeutics Files 6-K with Meeting Results
Ticker: PRNAF · Form: 6-K · Filed: Mar 31, 2025 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, filing-update, registration-statement
Related Tickers: ATHE
TL;DR
ALTERITY THERAPEUTICS LTD (ATHE) filed a 6-K on 3/31/25 for meeting results, incorporated into S-8/F-3 filings.
AI Summary
Alterity Therapeutics Limited filed a Form 6-K on March 31, 2025, reporting the results of a meeting. This filing is incorporated by reference into several of their existing registration statements on Form S-8 and Form F-3. The company, formerly known as PRANA BIOTECHNOLOGY LTD, is a development stage enterprise based in Melbourne, Australia.
Why It Matters
This filing indicates ongoing corporate activities and updates, potentially affecting investor understanding of the company's operational status and regulatory compliance.
Risk Assessment
Risk Level: low — This filing is a routine report of meeting results and incorporation by reference, not indicating new financial or operational risks.
Key Players & Entities
- Alterity Therapeutics Limited (company) — Registrant
- PRANA BIOTECHNOLOGY LTD (company) — Former company name
- March 2025 (date) — Reporting period
- 31, 2025 (date) — Filing date
- Form S-8 (document) — Incorporated filing
- Form F-3 (document) — Incorporated filing
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report the results of a meeting held by Alterity Therapeutics Limited during the month of March 2025.
Which registration statements is this 6-K filing being incorporated into?
This 6-K is being incorporated by reference into Alterity Therapeutics Limited's Registration Statements on Form S-8 (Files No. 333-251073, 333-248980, and 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417, and 333-250076).
What was Alterity Therapeutics Limited's former company name?
Alterity Therapeutics Limited was formerly known as PRANA BIOTECHNOLOGY LTD.
When was this Form 6-K filed?
This Form 6-K was filed on March 31, 2025.
What type of company is Alterity Therapeutics Limited described as in the filing?
Alterity Therapeutics Limited is described as a development stage enterprise.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 31, 2025 regarding ALTERITY THERAPEUTICS LTD (PRNAF).